Well, folks, this week I’m having a miniature vacation, and I’m going to spend the afternoon on the whitewater rapids of the melting snow of the Sierras. I’ll return this evening to let you know if I made it.

Slope initially began as a blog, so this is where most of the website’s content resides. Here we have tens of thousands of posts dating back over a decade. These are listed in reverse chronological order. Click on any category icon below to see posts tagged with that particular subject, or click on a word in the category cloud on the right side of the screen for more specific choices.
Well, folks, this week I’m having a miniature vacation, and I’m going to spend the afternoon on the whitewater rapids of the melting snow of the Sierras. I’ll return this evening to let you know if I made it.

XBI is a small/mid cap fund with a relative equal-weighting of biotech stocks. IBB is a market-cap weighted fund skewed towards the large-caps. Simple thesis: if investors are bullish they should like biotech, all else equal. If they’re nervous, they will not like small, cash burning companies that face existential risk in an extended bear market or recession.
In late June 2022, I noticed $XBI had been outperforming QQQ. It also bottomed in May and didn’t follow with a new low in June. I took that as a sign the market decline into June was probably running out of steam.

I wanted to offer some charts of interesting bearish setups of equities that aren’t particularly attractive as options plays (due to modest volume or thinly-traded options) but perhaps could be good, simple short-sales.
